Juan Zhou - Publications

Integrated transcriptomic and metabolomic analyses reveal targeting hexokinase 2 disrupts glycolysis and nucleotide metabolism to inhibit NSCLC growth.

Journal: World journal of surgical oncology

Published: August 11, 2025

Association between monocyte-to-lymphocyte ratio and cardiovascular diseases: insights from NHANES data.

Journal: Diabetology & metabolic syndrome

Published: November 12, 2024

Study on the Predictive Value of Renal Resistive Index Combined with β2-Microglobulin in Patients with Urosepsis Complicated with Acute Kidney Injury.

Journal: Journal of inflammation research

Published: August 24, 2024

Correction: Promoter-regulated in vivo asymmetric self-assembly strategy to synthesize heterogeneous nanoparticles for signal amplification.

Journal: Nanoscale

Published: May 20, 2024

Removal of inflammatory factors and prognosis of patients with septic shock complicated with acute kidney injury by hemodiafiltration combined with HA330-II hemoperfusion.

Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

Published: July 25, 2023

Impact of lymphadenectomy extent on immunotherapy efficacy in postresectional recurred non-small cell lung cancer: a multi-institutional retrospective cohort study.

Journal: International journal of surgery (London, England)

Published: June 19, 2023

Full spectrum flow cytometry-powered comprehensive analysis of PBMC as biomarkers for immunotherapy in NSCLC with EGFR-TKI resistance.

Journal: Biological procedures online

Published: June 15, 2023

Influence of Exosomes on Astrocytes in the Pre-Metastatic Niche of Lung Cancer Brain Metastases.

Journal: Biological procedures online

Published: December 31, 2022

Promoter-regulated in vivo asymmetric self-assembly strategy to synthesize heterogeneous nanoparticles for signal amplification.

Journal: Nanoscale

Published: October 24, 2022

Chiral Covalent Organic Framework Packed Nanochannel Membrane for Enantioseparation.

Journal: Angewandte Chemie (International ed. in English)

Published: April 17, 2022

Increased blood-based intratumor heterogeneity (bITH) is associated with unfavorable outcomes of immune checkpoint inhibitors plus chemotherapy in non-small cell lung cancer.

Journal: BMC medicine

Published: March 02, 2022

Special issue "The advance of solid tumor research in China": Real-world clinical outcomes of alectinib for advanced nonsmall-cell lung cancer patients with ALK fusion in China.

Journal: International journal of cancer

Published: November 02, 2021